Daunorubicin-prednisone remission induction with hydroxyurea maintenance in acute non-lymphocytic leukemia
- 1 April 1973
- Vol. 31 (4) , 931-938
- https://doi.org/10.1002/1097-0142(197304)31:4<931::aid-cncr2820310426>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- High-dose daunorubicin therapy for acute nonlymphocytic leukemia: Correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activityCancer, 1972
- Daunorubicin therapy in adult acute lymphatic leukemiaCancer, 1972
- RUBIDOMYCIN IN BLASTIC PHASES OF ACUTE PROMYELOCYTIC AND MYELOBLASTIC LEUKEMIA IN CHILDRENActa Paediatrica, 1971
- FACTORS EFFECTING REMISSION AND SURVIVAL IN ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)Medicine, 1970
- Daunorubicin in acute leukaemiaPublished by Oxford University Press (OUP) ,1970
- DAUNORUBICIN IN THE TREATMENT OF ADULT ACUTE LEUKAEMIAThe Medical Journal of Australia, 1970
- Daunorubicine in Acute Myelogenous Leukemia in AdultsJAMA, 1969
- DAUNORUBICIN IN THE TREATMENT OF ACUTE MYELOCYTIC LEUKÆMIAThe Lancet, 1969
- Rubidomycin in Acute Leukaemia in AdultsBMJ, 1968
- Daunomycin–Preliminary Results of the Treatment of Acute Leukemias in AdultsOncology, 1968